Literature DB >> 7909714

Changes of plasma concentrations of interleukin-1 alpha and interleukin-6 with neuroleptic treatment for schizophrenia.

H M Xu1, J Wei, G P Hemmings.   

Abstract

A significant difference of plasma interleukin (IL)-1 alpha concentration was found between schizophrenic patients taking neuroleptic drugs (n = 38) and those not taking them (n = 14; P < 0.02); Kruskal-Wallis analysis revealed a significant difference of plasma IL-6 concentration among the patients taking neuroleptic drugs, those not taking them, and healthy control subjects (H = 7.1, d.f. = 2, P < 0.05); also, there was a significant difference of plasma IL-6 concentration between the patients taking neuroleptic drugs (n = 32) and those not taking them (n = 13; P < 0.01). No significant differences were found between the three groups in the concentrations of IL-1 beta, IL-2 and tumour necrosis factor (TNF)-alpha. The present results suggest that neuroleptic treatment may change IL-1 alpha and IL-6 production in schizophrenic patients.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7909714     DOI： 10.1192/bjp.164.2.251

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN： 0007-1250            Impact factor:   9.319


  11 in total

1.  Decreased serum TNF-alpha levels in chronic schizophrenia patients on long-term antipsychotics: correlation with psychopathology and cognition.

Authors:  Meng Han Lv; Yun Long Tan; Shao Xiao Yan; Li Tian; Da Chun Chen; Shu Ping Tan; Zhi Ren Wang; Fu De Yang; Jin H Yoon; Giovana B Zunta-Soares; Jair C Soares; Xiang Yang Zhang
Journal:  Psychopharmacology (Berl)       Date:  2014-06-24       Impact factor: 4.530

2.  Imaging Microglial Activation in Untreated First-Episode Psychosis: A PET Study With [18F]FEPPA.

Authors:  Sina Hafizi; Huai-Hsuan Tseng; Naren Rao; Thiviya Selvanathan; Miran Kenk; Richard P Bazinet; Ivonne Suridjan; Alan A Wilson; Jeffrey H Meyer; Gary Remington; Sylvain Houle; Pablo M Rusjan; Romina Mizrahi
Journal:  Am J Psychiatry       Date:  2016-09-09       Impact factor: 18.112

3.  Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects.

Authors:  Brian J Miller; Peter Buckley; Wesley Seabolt; Andrew Mellor; Brian Kirkpatrick
Journal:  Biol Psychiatry       Date:  2011-06-08       Impact factor: 13.382

4.  Inflammation in Schizophrenia: Cytokine Levels and Their Relationships to Demographic and Clinical Variables.

Authors:  Ellen E Lee; Suzi Hong; Averria Sirkin Martin; Lisa T Eyler; Dilip V Jeste
Journal:  Am J Geriatr Psychiatry       Date:  2016-10-17       Impact factor: 4.105

Review 5.  Methodological Issues in Cytokine Measurement in Schizophrenia.

Authors:  Maju Mathew Koola
Journal:  Indian J Psychol Med       Date:  2016 Jan-Feb

6.  Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission.

Authors:  U H Frommberger; J Bauer; P Haselbauer; A Fräulin; D Riemann; M Berger
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

7.  Association study of interleukin 2 (IL2) and IL4 with schizophrenia in a Japanese population.

Authors:  Yuichiro Watanabe; Ayako Nunokawa; Masako Shibuya; Naoshi Kaneko; Hiroyuki Nawa; Toshiyuki Someya
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06-20       Impact factor: 5.270

8.  Lower serum cytokine levels in smokers than nonsmokers with chronic schizophrenia on long-term treatment with antipsychotics.

Authors:  Xiang Yang Zhang; Lian Yuan Cao; Cai Song; Gui Ying Wu; Da Chun Chen; Ling Yan Qi; Fan Wang; Mei Hong Xiu; Song Chen; Yingyang Zhang; Lin Lu; Therese A Kosten; Thomas R Kosten
Journal:  Psychopharmacology (Berl)       Date:  2008-08-22       Impact factor: 4.530

9.  Possible association between interleukin-1β gene and schizophrenia in a Japanese population.

Authors:  Daimei Sasayama; Hiroaki Hori; Toshiya Teraishi; Kotaro Hattori; Miho Ota; Yoshimi Iijima; Masahiko Tatsumi; Teruhiko Higuchi; Naoji Amano; Hiroshi Kunugi
Journal:  Behav Brain Funct       Date:  2011-08-16       Impact factor: 3.759

10.  Serum IL-1beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment.

Authors:  A B Erbağci; H Herken; O Köylüoglu; N Yilmaz; M Tarakçioglu
Journal:  Mediators Inflamm       Date:  2001-06       Impact factor: 4.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.